CSF2 and head and neck cancer: Regarding the use of GM-CSF, the study published by Chi et al. in 1995 (23) found the systemic administration of GM-CSF in patients with head and neck cancer subjected to chemotherapy (5-fluorouracil and cisplatin) to reduce the severity and duration of oral mucositis.